Skip to main content
. 2015 Nov 20;9:2159–2174. doi: 10.2147/OPTH.S92359

Figure 3.

Figure 3

An eye with neovascularization-associated RPE atrophy at the baseline (A) and 30 months after anti-VEGF treatment (B).

Notes: With resolution of subretinal fluid, fibrin, and thin fibrovascular material at the baseline, the eye has developed marked RPE loss in the central macula.

Abbreviations: RPE, retinal pigment epithelium; VEGF, vascular endothelial growth factor.